Tuberculosis disease: Difference between revisions

Revision as of 07:00, 22 July 2013

This student page has not been curated.

Mycobacterium tuberculosis under microscope [1]

Etiology/Bacteriology

Taxonomy

Mycobacterium tuberculosis Stain [2]

Kingdom: Bacteria
Phylum: Actinobacteria
Class: Actinobacteria
Order: Actinomycetales
Family: Mycobacteriaceae
Genus: Mycobacterium
Species: tuberculosis

Description

Mycobacterium tuberculosis Stain [3]

Pathogenesis

Transmission

Infectious Dose, Incubation, and Colonization

Epidemiology

Virulence Factors

Clinical Features and Symptoms

Mycobacterium tuberculosis presented via X Ray [4]

Diagnosis

Treatment

Prevention

Host Immune Response

Tuberculosis acts in a two-step mechanism that begins with a primary infection and as the host deteriorates the secondary disease can occur. When infected with the Mycobacterium tuberculosis a healthy individual with a strong immune system presents asymptomatically or with mild flu like symptoms. Due to being of low to no risk, most patients are left with these bacteria growing and colonizing within their body. Pulmonary tuberculosis infections begin with the Mycobacterium tuberculosis invading and reproducing within the macrophages residing in the infected alveoli. As immune cells make their way to the lymph nodes, the adaptive immune response is initiated by T cells. At this point multiple sites of the body are experiencing the process of inflammation. Not much is known about the immune system and how Mycobacterium tuberculosis effects it.

References

1 Conway, Tyrrell. “Genus conway”. “Microbe Wiki” 2013. Volume 1. p. 1-2.

@@ Line 41: / Line 41: @@
 ==Prevention==
-There is currently a vaccine, Bacillua Calmette-Guerin (BCG), which aims protect certain groups from the disease, although is 100% effective. The criteria for this vaccine varies depending on the country one resides. In the United States, a vaccine is not given until the set guidelines have been met and the patient has been seen by a doctor considered an expert with the TB disease. The guidelines broken down into two categories for the United States are: <br>
-<b> Children </b>
-<ul>
-<li> An accredited hospital has recorded the patient is TB positive, through the reading of a skin test</li>
-<li> The child must remain in contact with persons diagnosed with TB that are not or inadequately treated for the disease </li>
-<li> The child must remain in contact with persons that were infected with <i>Mycobacterium tuberculosis</i> that is resistant to the antibiotics isoniazid and rifampin </li>
-</ul>
-<b> Health Care Workers </b>
-The consideration for this vaccine is only on an individual basis, in which the person
-<ul>
-<li> Is in contact with a large population of TB patients infected with <i>Mycobacterium tuberculosis</i> that is resistant to isoniazid and rifampin </li>
-<li> Drug-resistant TB is being transmitted between health care workers</li>
-<li> Widespread preventative measures against the spread of TB have been implemented, but deemed unsuccessful </li>
-</ul>
-Most patients vaccinated with the BCG vaccine will proved a positive TB skin test, due to their immunological memory and the exposure of <i> Mycobacterium tuberculosis</i>.
-<br>
-<br>
-In most cases the prevention of TB is related to how the disease is controlled. There are many different measures that need to be controlled when a TB prevention plan is put into effect.
 ==Host Immune Response==